Dravix™ (Tranexamic Acid)

Getz Pharma (Pvt) Limited offers a wide range of products which includes  Dravix™Indication: For the treatment of: Hemorrhage or risk of hemorrhage in increased fibrinolysis or fibrinogenolysis.  Local fibrinolysis may occur in the following conditions: Prostatectomy and bladder surgery Menorrhagia Epistaxis Conisation of the cervix Management of dental extraction in patients with coagulopathies Ulcerative colitis Hematuria Gastrointestinal hemorrhage. General fibrinolysis as in prostatic and pancreatic cancer; after thoracic and other major surgery: in obstetrical complications such as abruptio placentae and post-partum hemorrhagein leukemia and liver diseases and in connection with thrombolytic therapy with streptokinaseHereditary angioneurotic oedema: For the reduction of peri- and post-operative blood loss and the need for blood transfusion inadult patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. For the reduction of peri- and post-operative blood loss and the need for blood transfusion inpediatric patients undergoing cardiac surgery. For more information contact us at www.getzpharma.com